 | • レポートコード：MRC2Q12-19415 • 出版社/出版日：QYResearch / 2022年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥710,500 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,421,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、シルデナフィル薬剤のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 シルデナフィル薬剤のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 シルデナフィル薬剤の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 シルデナフィル薬剤のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのシルデナフィル薬剤の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のシルデナフィル薬剤の売上および2028年までの予測に焦点を当てています。 シルデナフィル薬剤のグローバル主要企業には、Pfizer、Lupin Laboratories、Unichem Laboratories、Torrent Pharmaceuticals、Sandoz、Osho Pharma、Atlas Laboratories Pvt Ltd、Yabang Pharma、Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd、Centurion Laboratories、Teva Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 シルデナフィル薬剤市場は、タイプとアプリケーションによって区分されます。世界のシルデナフィル薬剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 25mg、50mg、100mg 【アプリケーション別セグメント】 病院薬局、小売店薬局、オンライン薬局 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - シルデナフィル薬剤製品概要 - タイプ別市場（25mg、50mg、100mg） - アプリケーション別市場（病院薬局、小売店薬局、オンライン薬局） - 調査の目的 ・エグゼクティブサマリー - 世界のシルデナフィル薬剤販売量予測2017-2028 - 世界のシルデナフィル薬剤売上予測2017-2028 - シルデナフィル薬剤の地域別販売量 - シルデナフィル薬剤の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別シルデナフィル薬剤販売量 - 主要メーカー別シルデナフィル薬剤売上 - 主要メーカー別シルデナフィル薬剤価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（25mg、50mg、100mg） - シルデナフィル薬剤のタイプ別販売量 - シルデナフィル薬剤のタイプ別売上 - シルデナフィル薬剤のタイプ別価格 ・アプリケーション別市場規模（病院薬局、小売店薬局、オンライン薬局） - シルデナフィル薬剤のアプリケーション別販売量 - シルデナフィル薬剤のアプリケーション別売上 - シルデナフィル薬剤のアプリケーション別価格 ・北米市場 - 北米のシルデナフィル薬剤市場規模（タイプ別、アプリケーション別） - 主要国別のシルデナフィル薬剤市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのシルデナフィル薬剤市場規模（タイプ別、アプリケーション別） - 主要国別のシルデナフィル薬剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のシルデナフィル薬剤市場規模（タイプ別、アプリケーション別） - 主要国別のシルデナフィル薬剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のシルデナフィル薬剤市場規模（タイプ別、アプリケーション別） - 主要国別のシルデナフィル薬剤市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのシルデナフィル薬剤市場規模（タイプ別、アプリケーション別） - 主要国別のシルデナフィル薬剤市場規模（トルコ、サウジアラビア） ・企業情報 Pfizer、Lupin Laboratories、Unichem Laboratories、Torrent Pharmaceuticals、Sandoz、Osho Pharma、Atlas Laboratories Pvt Ltd、Yabang Pharma、Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd、Centurion Laboratories、Teva Pharmaceuticals ・産業チェーン及び販売チャネル分析 - シルデナフィル薬剤の産業チェーン分析 - シルデナフィル薬剤の原材料 - シルデナフィル薬剤の生産プロセス - シルデナフィル薬剤の販売及びマーケティング - シルデナフィル薬剤の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - シルデナフィル薬剤の産業動向 - シルデナフィル薬剤のマーケットドライバー - シルデナフィル薬剤の課題 - シルデナフィル薬剤の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Sildenafil Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Sildenafil Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Sildenafil Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Sildenafil Drug include Pfizer, Lupin Laboratories, Unichem Laboratories, Torrent Pharmaceuticals, Sandoz, Osho Pharma, Atlas Laboratories Pvt Ltd, Yabang Pharma and Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Sildenafil Drug manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Sildenafil Drug market. Further, it explains the major drivers and regional dynamics of the global Sildenafil Drug market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Pfizer
Lupin Laboratories
Unichem Laboratories
Torrent Pharmaceuticals
Sandoz
Osho Pharma
Atlas Laboratories Pvt Ltd
Yabang Pharma
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Centurion Laboratories
Teva Pharmaceuticals
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by dosage form and by application segments based on sales, price, and value for the period 2017-2028.
Sildenafil Drug Segment by Dosage Form
25mg
50mg
100mg
Sildenafil Drug Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Sildenafil Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Sildenafil Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Sildenafil Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Sildenafil Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sildenafil Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Sildenafil Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Sildenafil Drug sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Lupin Laboratories, Unichem Laboratories, Torrent Pharmaceuticals, Sandoz, Osho Pharma, Atlas Laboratories Pvt Ltd, Yabang Pharma and Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Sildenafil Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Sildenafil Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by dosage form, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by dosage form, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by dosage form, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by dosage form, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by dosage form, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sildenafil Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Sildenafil Drug Product Introduction
1.2 Market by Dosage Form
1.2.1 Global Sildenafil Drug Market Size Growth Rate by Dosage Form, 2017 VS 2021 VS 2028
1.2.2 25mg
1.2.3 50mg
1.2.4 100mg
1.3 Market by Application
1.3.1 Global Sildenafil Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Sildenafil Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Sildenafil Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Sildenafil Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Sildenafil Drug Sales by Region
2.4.1 Global Sildenafil Drug Sales by Region (2017-2022)
2.4.2 Global Sales Sildenafil Drug by Region (2023-2028)
2.5 Global Sildenafil Drug Revenue by Region
2.5.1 Global Sildenafil Drug Revenue by Region (2017-2022)
2.5.2 Global Sildenafil Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Sildenafil Drug Sales by Manufacturers
3.1.1 Global Top Sildenafil Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Sildenafil Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sildenafil Drug in 2021
3.2 Global Sildenafil Drug Revenue by Manufacturers
3.2.1 Global Sildenafil Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Sildenafil Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Sildenafil Drug Revenue in 2021
3.3 Global Sildenafil Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Sildenafil Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Sildenafil Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Dosage Form
4.1 Global Sildenafil Drug Sales by Dosage Form
4.1.1 Global Sildenafil Drug Historical Sales by Dosage Form (2017-2022)
4.1.2 Global Sildenafil Drug Forecasted Sales by Dosage Form (2023-2028)
4.1.3 Global Sildenafil Drug Sales Market Share by Dosage Form (2017-2028)
4.2 Global Sildenafil Drug Revenue by Dosage Form
4.2.1 Global Sildenafil Drug Historical Revenue by Dosage Form (2017-2022)
4.2.2 Global Sildenafil Drug Forecasted Revenue by Dosage Form (2023-2028)
4.2.3 Global Sildenafil Drug Revenue Market Share by Dosage Form (2017-2028)
4.3 Global Sildenafil Drug Price by Dosage Form
4.3.1 Global Sildenafil Drug Price by Dosage Form (2017-2022)
4.3.2 Global Sildenafil Drug Price Forecast by Dosage Form (2023-2028)
5 Market Size by Application
5.1 Global Sildenafil Drug Sales by Application
5.1.1 Global Sildenafil Drug Historical Sales by Application (2017-2022)
5.1.2 Global Sildenafil Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Sildenafil Drug Sales Market Share by Application (2017-2028)
5.2 Global Sildenafil Drug Revenue by Application
5.2.1 Global Sildenafil Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Sildenafil Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Sildenafil Drug Revenue Market Share by Application (2017-2028)
5.3 Global Sildenafil Drug Price by Application
5.3.1 Global Sildenafil Drug Price by Application (2017-2022)
5.3.2 Global Sildenafil Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Sildenafil Drug Market Size by Dosage Form
6.1.1 North America Sildenafil Drug Sales by Dosage Form (2017-2028)
6.1.2 North America Sildenafil Drug Revenue by Dosage Form (2017-2028)
6.2 North America Sildenafil Drug Market Size by Application
6.2.1 North America Sildenafil Drug Sales by Application (2017-2028)
6.2.2 North America Sildenafil Drug Revenue by Application (2017-2028)
6.3 North America Sildenafil Drug Market Size by Country
6.3.1 North America Sildenafil Drug Sales by Country (2017-2028)
6.3.2 North America Sildenafil Drug Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Sildenafil Drug Market Size by Dosage Form
7.1.1 Europe Sildenafil Drug Sales by Dosage Form (2017-2028)
7.1.2 Europe Sildenafil Drug Revenue by Dosage Form (2017-2028)
7.2 Europe Sildenafil Drug Market Size by Application
7.2.1 Europe Sildenafil Drug Sales by Application (2017-2028)
7.2.2 Europe Sildenafil Drug Revenue by Application (2017-2028)
7.3 Europe Sildenafil Drug Market Size by Country
7.3.1 Europe Sildenafil Drug Sales by Country (2017-2028)
7.3.2 Europe Sildenafil Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Sildenafil Drug Market Size by Dosage Form
8.1.1 Asia Pacific Sildenafil Drug Sales by Dosage Form (2017-2028)
8.1.2 Asia Pacific Sildenafil Drug Revenue by Dosage Form (2017-2028)
8.2 Asia Pacific Sildenafil Drug Market Size by Application
8.2.1 Asia Pacific Sildenafil Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Sildenafil Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Sildenafil Drug Market Size by Region
8.3.1 Asia Pacific Sildenafil Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Sildenafil Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Sildenafil Drug Market Size by Dosage Form
9.1.1 Latin America Sildenafil Drug Sales by Dosage Form (2017-2028)
9.1.2 Latin America Sildenafil Drug Revenue by Dosage Form (2017-2028)
9.2 Latin America Sildenafil Drug Market Size by Application
9.2.1 Latin America Sildenafil Drug Sales by Application (2017-2028)
9.2.2 Latin America Sildenafil Drug Revenue by Application (2017-2028)
9.3 Latin America Sildenafil Drug Market Size by Country
9.3.1 Latin America Sildenafil Drug Sales by Country (2017-2028)
9.3.2 Latin America Sildenafil Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Sildenafil Drug Market Size by Dosage Form
10.1.1 Middle East and Africa Sildenafil Drug Sales by Dosage Form (2017-2028)
10.1.2 Middle East and Africa Sildenafil Drug Revenue by Dosage Form (2017-2028)
10.2 Middle East and Africa Sildenafil Drug Market Size by Application
10.2.1 Middle East and Africa Sildenafil Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Sildenafil Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Sildenafil Drug Market Size by Country
10.3.1 Middle East and Africa Sildenafil Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Sildenafil Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Sildenafil Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Sildenafil Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Lupin Laboratories
11.2.1 Lupin Laboratories Corporation Information
11.2.2 Lupin Laboratories Overview
11.2.3 Lupin Laboratories Sildenafil Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Lupin Laboratories Sildenafil Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Lupin Laboratories Recent Developments
11.3 Unichem Laboratories
11.3.1 Unichem Laboratories Corporation Information
11.3.2 Unichem Laboratories Overview
11.3.3 Unichem Laboratories Sildenafil Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Unichem Laboratories Sildenafil Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Unichem Laboratories Recent Developments
11.4 Torrent Pharmaceuticals
11.4.1 Torrent Pharmaceuticals Corporation Information
11.4.2 Torrent Pharmaceuticals Overview
11.4.3 Torrent Pharmaceuticals Sildenafil Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Torrent Pharmaceuticals Sildenafil Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Torrent Pharmaceuticals Recent Developments
11.5 Sandoz
11.5.1 Sandoz Corporation Information
11.5.2 Sandoz Overview
11.5.3 Sandoz Sildenafil Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sandoz Sildenafil Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sandoz Recent Developments
11.6 Osho Pharma
11.6.1 Osho Pharma Corporation Information
11.6.2 Osho Pharma Overview
11.6.3 Osho Pharma Sildenafil Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Osho Pharma Sildenafil Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Osho Pharma Recent Developments
11.7 Atlas Laboratories Pvt Ltd
11.7.1 Atlas Laboratories Pvt Ltd Corporation Information
11.7.2 Atlas Laboratories Pvt Ltd Overview
11.7.3 Atlas Laboratories Pvt Ltd Sildenafil Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Atlas Laboratories Pvt Ltd Sildenafil Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Atlas Laboratories Pvt Ltd Recent Developments
11.8 Yabang Pharma
11.8.1 Yabang Pharma Corporation Information
11.8.2 Yabang Pharma Overview
11.8.3 Yabang Pharma Sildenafil Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Yabang Pharma Sildenafil Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Yabang Pharma Recent Developments
11.9 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
11.9.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Corporation Information
11.9.2 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Overview
11.9.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Sildenafil Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Sildenafil Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Developments
11.10 Centurion Laboratories
11.10.1 Centurion Laboratories Corporation Information
11.10.2 Centurion Laboratories Overview
11.10.3 Centurion Laboratories Sildenafil Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Centurion Laboratories Sildenafil Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Centurion Laboratories Recent Developments
11.11 Teva Pharmaceuticals
11.11.1 Teva Pharmaceuticals Corporation Information
11.11.2 Teva Pharmaceuticals Overview
11.11.3 Teva Pharmaceuticals Sildenafil Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Teva Pharmaceuticals Sildenafil Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Teva Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Sildenafil Drug Industry Chain Analysis
12.2 Sildenafil Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Sildenafil Drug Production Mode & Process
12.4 Sildenafil Drug Sales and Marketing
12.4.1 Sildenafil Drug Sales Channels
12.4.2 Sildenafil Drug Distributors
12.5 Sildenafil Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Sildenafil Drug Industry Trends
13.2 Sildenafil Drug Market Drivers
13.3 Sildenafil Drug Market Challenges
13.4 Sildenafil Drug Market Restraints
14 Key Findings in The Global Sildenafil Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
| 【シルデナフィル薬剤について】 シルデナフィルは、主に勃起不全の治療に使用される医薬品であり、その特性や用途において広く知られています。以下に、シルデナフィルという薬剤の概念について詳述します。 まず、シルデナフィルの定義ですが、これは主に男性の勃起機能不全を改善する目的で開発された選択的なホスホジエステラーゼ5（PDE5）阻害薬です。1998年にアメリカの製薬会社ファイザーによって承認され、商標名「バイアグラ」として広く流通しています。シルデナフィルは、他の類似薬剤とともに、ED（勃起不全）治療薬としての代表的な存在となっています。 シルデナフィルの特徴として、まずその作用機序が挙げられます。この薬剤は、陰茎の血管を拡張させることで、性的刺激に反応して勃起が促進されるという仕組みです。具体的には、性的刺激により一酸化窒素（NO）が放出され、これがグアニル酸シクラーゼ（GC）を活性化し、サイクリックGMP（cGMP）の濃度が増加します。このcGMPは、血管平滑筋の弛緩を引き起こし、結果としてペニスの血流が増加し、勃起が可能となるのです。シルデナフィルはこのcGMPを分解するPDE5の活動を阻害することで、効果を発揮します。 この薬剤は、錠剤の形で服用され、通常は性行為の約30分から1時間前に服用することが推奨されます。効果は最大で約4～6時間持続しますが、個人差があり、食事の内容や他の医薬品との相互作用によっても影響を受けることがあります。 シルデナフィルには主に2つの種類があります。一つは通常のシルデナフィルで、もう一つはその改良型であるシルデナフィル・シトレート（Sildenafil Citrate）です。医療機関での処方を通じて、個々の患者の症状や健康状態に応じて適切な種類が選択されます。 また、シルデナフィルは勃起不全の他にも様々な用途があります。一部の疾患において、血管を拡張する作用を利用して高血圧や肺動脈性高血圧症の治療にも用いられています。特に肺動脈性高血圧症に対しては、シルデナフィルの作用が有効であることが臨床研究などで示されています。 さらに、近年の研究では、シルデナフィルが心血管系の健康にも寄与する可能性が示唆されています。心血管疾患を抱える患者に対して、血管拡張作用がもたらす利点が期待されており、心臓の血流量を改善することが示されています。 関連技術として、シルデナフィルはその効果を持続させるための新しい製剤や投与方法に関連する研究が進行しています。例えば、持続的な効果を狙った徐放性製剤や、局所投与による新しい治療法が検討されています。また、他のED治療薬との比較研究なども行われており、患者のライフスタイルや治療ニーズに応じた新たな選択肢としての可能性を秘めています。 シルデナフィルの使用にあたっては、副作用のリスクも十分に理解しておく必要があります。一般的な副作用として、頭痛、顔面紅潮、消化不良、視覚障害などがあります。特に視覚に関する副作用は、シルデナフィルを服用した際に一過性の青色色覚異常を訴える患者がいることから注意が必要です。さらに、心疾患を抱える患者や、硝酸剤を服用している方には高血圧のもとでの相互作用リスクがあるため、特に慎重な対応が求められます。 シルデナフィルはその普及に伴い、性に関するタブーを減少させ、誰もが健康的な性的機能を享受できる社会への一助となる可能性があります。情報の普及とともに、その使用が一般化することで、多くの男性が直面する勃起不全に対する理解と治療の選択肢が広がることが期待されています。治療に対する偏見を減少させ、患者が安心して使用できる環境が整備されることが重要です。 以上のように、シルデナフィルはその効果や使用方法において多くの特徴を持つ薬剤です。ED治療薬としての位置づけが確立され、様々な疾患に対する応用が進む中、今後も研究や技術の進展が期待されます。シルデナフィルを使用する際は、医師の指導の下で適切に利用することが重要であり、正しい情報に基づいた理解が必要です。 |